| Product Code: ETC10185678 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India primary immunodeficiency disorders market import shipment demonstrated robust expansion with a high CAGR from 2020-2024. The growth rate notably accelerated between 2023 and 2024, indicating increasing momentum. The market exhibited a clear upward trend, showcasing significant growth potential.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Primary Immunodeficiency Disorders Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Primary Immunodeficiency Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 India Primary Immunodeficiency Disorders Market - Industry Life Cycle |
3.4 India Primary Immunodeficiency Disorders Market - Porter's Five Forces |
3.5 India Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Disorder Type, 2021 & 2031F |
3.6 India Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 India Primary Immunodeficiency Disorders Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Primary Immunodeficiency Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about primary immunodeficiency disorders in India |
4.2.2 Rising prevalence of primary immunodeficiency disorders in the country |
4.2.3 Growing healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for diagnosing and treating primary immunodeficiency disorders |
4.3.2 High cost associated with treatments and therapies for primary immunodeficiency disorders |
4.3.3 Lack of reimbursement policies and insurance coverage for specialized treatments |
5 India Primary Immunodeficiency Disorders Market Trends |
6 India Primary Immunodeficiency Disorders Market, By Types |
6.1 India Primary Immunodeficiency Disorders Market, By Disorder Type |
6.1.1 Overview and Analysis |
6.1.2 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Disorder Type, 2021 - 2031F |
6.1.3 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Antibody Deficiency, 2021 - 2031F |
6.1.4 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Combined Immunodeficiency, 2021 - 2031F |
6.1.5 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Phagocytic Deficiency, 2021 - 2031F |
6.1.6 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Complement Deficiency, 2021 - 2031F |
6.2 India Primary Immunodeficiency Disorders Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Immunoglobulin Replacement, 2021 - 2031F |
6.2.3 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Bone Marrow Transplant, 2021 - 2031F |
6.2.4 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Enzyme Replacement, 2021 - 2031F |
6.2.5 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.3 India Primary Immunodeficiency Disorders Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 India Primary Immunodeficiency Disorders Market Revenues & Volume, By IVIG, 2021 - 2031F |
6.3.3 India Primary Immunodeficiency Disorders Market Revenues & Volume, By SCIG, 2021 - 2031F |
6.3.4 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3.5 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Small Molecule Drugs, 2021 - 2031F |
6.4 India Primary Immunodeficiency Disorders Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 India Primary Immunodeficiency Disorders Market Revenues & Volume, By Homecare, 2021 - 2031F |
7 India Primary Immunodeficiency Disorders Market Import-Export Trade Statistics |
7.1 India Primary Immunodeficiency Disorders Market Export to Major Countries |
7.2 India Primary Immunodeficiency Disorders Market Imports from Major Countries |
8 India Primary Immunodeficiency Disorders Market Key Performance Indicators |
8.1 Number of patients diagnosed with primary immunodeficiency disorders |
8.2 Adoption rate of advanced treatments and therapies for primary immunodeficiency disorders |
8.3 Investment in research and development for new treatments and diagnostic tools |
9 India Primary Immunodeficiency Disorders Market - Opportunity Assessment |
9.1 India Primary Immunodeficiency Disorders Market Opportunity Assessment, By Disorder Type, 2021 & 2031F |
9.2 India Primary Immunodeficiency Disorders Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Primary Immunodeficiency Disorders Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 India Primary Immunodeficiency Disorders Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Primary Immunodeficiency Disorders Market - Competitive Landscape |
10.1 India Primary Immunodeficiency Disorders Market Revenue Share, By Companies, 2024 |
10.2 India Primary Immunodeficiency Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here